These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 16111085

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Palonosetron in the prevention of chemotherapy-induced nausea and vomiting (CINV) in Italy: pharmacologic, clinical and economic aspects].
    Pradelli L, Eandi M.
    Tumori; 2008; 94(2):suppl 26-32. PubMed ID: 18564623
    [No Abstract] [Full Text] [Related]

  • 3. Palonosetron: a unique 5-HT3 receptor antagonist indicated for the prevention of acute and delayed chemotherapy-induced nausea and vomiting.
    Rubenstein EB.
    Clin Adv Hematol Oncol; 2004 May; 2(5):284-9. PubMed ID: 16163194
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Antiemetic control: 5-HT3 antagonists: review of clinical results, with particular emphasis on ondansetron.
    Kidgell AE, Butcher ME, Brown GW.
    Cancer Treat Rev; 1990 Sep; 17(2-3):311-7. PubMed ID: 2176933
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Ondansetron and tropisetron in the control of nausea and vomiting in children receiving combined cancer chemotherapy.
    Stiakaki E, Savvas S, Lydaki E, Bolonaki I, Kouvidi E, Dimitriou H, Kambourakis A, Kalmanti M.
    Pediatr Hematol Oncol; 1999 Sep; 16(2):101-8. PubMed ID: 10100270
    [Abstract] [Full Text] [Related]

  • 12. A meta-analysis comparing the efficacy of four 5-HT3-receptor antagonists for acute chemotherapy-induced emesis.
    Jordan K, Hinke A, Grothey A, Voigt W, Arnold D, Wolf HH, Schmoll HJ.
    Support Care Cancer; 2007 Sep; 15(9):1023-33. PubMed ID: 17205281
    [Abstract] [Full Text] [Related]

  • 13. Clinical evaluation of two antiemetic combinations palonosetron dexamethasone versus ondansetron dexamethasone in chemotherapy of head and neck cancer.
    Kaushal J, Gupta MC, Kaushal V, Bhutani G, Dhankar R, Atri R, Verma S.
    Singapore Med J; 2010 Nov; 51(11):871-5. PubMed ID: 21140114
    [Abstract] [Full Text] [Related]

  • 14. Serotonin antagonists for nausea and vomiting.
    Gastroenterol Nurs; 2014 Nov; 37(2):184-6. PubMed ID: 24691090
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antiemetic efficacy of three serotonin antagonists during high-dose chemotherapy and autologous stem cell transplantation in malignant lymphoma.
    Slabý J, Trnený M, Procházka B, Klener P.
    Neoplasma; 2000 Nov; 47(5):319-22. PubMed ID: 11130251
    [Abstract] [Full Text] [Related]

  • 20. [Recent improvements in antiemetic therapy].
    Roila F, Palladino MA, Ciccarese G, Basurto C.
    Tumori; 1997 Nov; 83(2 Suppl):S3-14. PubMed ID: 9235727
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.